Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance

Nature Medicine

Volumn 5, Issue 11, 1999, Pages 1303-1307

  Wells, Andrew D ^b   Li, Xian Chang ^a   Li, Yongsheng ^a   Walsh, Matthew C ^b   Zheng, Xin Xiao ^a   Wu, Zihao ^b   Nuñez, Gabriel ^c   Tang, Aimin ^b   Sayegh, Mohamed ^e   Hancock, Wayne W ^d   Strom, Terry B ^a   Turka, Laurence A ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d MILLENNIUM PHARMACEUTICALS INC   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 2; PROTEIN BCL X; RAPAMYCIN;

ALLOIMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CLONAL ANERGY; CONTROLLED STUDY; CYTOKINE RELEASE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION; APOPTOSIS; BCL-X PROTEIN; CELL DIVISION; FLOW CYTOMETRY; GRAFT SURVIVAL; IMMUNOCONJUGATES; MICE; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS C-BCL-2; T-LYMPHOCYTES; TRANSPLANTATION IMMUNOLOGY;

EID: 0345476290     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/15260     Document Type: Article

References (24)

1. Sykes, M. & Sachs, D. H. Bone marrow transplantation as a means of inducing tolerance. Semin. Immunol. 2, 401-417 (1990).
2. Schwartz, R. H. Acquisition of immunologic self-tolerance. Cell 57, 1073-1081 (1989).
3. Lenschow, D. et al. A. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science 257, 789-792 (1992).
4. Parker, D.C. et al. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc. Natl. Acad. Sci. USA 92, 9560-9564 (1995).
5. Larsen, C. P. et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381, 434-438 (1996).
6. Price, D. J., Grove, J. R., Calvo, V., Avruch, J. & Bierer, B. E. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. Science 257, 973-977 (1992).
7. Jenkins, M. K. & Schwartz, R. H. Antigen-presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165, 302-319 (1987).
8. Van Parijs, L. & Abbas, A. K. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 280, 243-248 (1998).
9. L displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion in transgenic mice. J. Exp. Med. 182, 1973-1983 (1995).
10. Lenardo, M. J. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis Nature 353, 858-861 (1991).
11. L. Immunity 3, 87-98 (1995).
12. O'Reilly, L. A., Huang, D. C. & Strasser, A. The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO J. 15, 6979-6990 (1996).
13. lo thymocytes in vivo. Science 1990, 1720-1723 (1990).
14. Gudmundsdottir, H., Wells, A. & Turka, L. Dynamics and requirements of T cell clonal expansion in vivo at the single-cell level: Effector function is linked to proliferative capacity. J. Immunol. 162, 5212-5223 (1999).
15. Hancock, W.W. et al. Co-stimulatory function and expression of CD40-ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc. Natl. Acad. Sci. USA 93, 13967-13972 (1996).
16. Kneitz, B., Herrmann, T., Yonehara, S. & Schimpl, A. Normal clonal expansion but impaired Fas-mediated cell death and anergy induction in interleukin-2-deficient mice. Eur. J. Immunol. 25, 2572-2577 (1995).
17. Wekerle, T. et al. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with co-stimulatory blockade is followed by central T cell tolerance. J. Exp. Med. 187, 2037-2044 (1998).
18. Dai, Z., Konieczny, B.T., Baddoura, F.K. & Lakkis, F.G. Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice. J. Immunol. 161, 1659-1663 (1998).
19. Sayegh, M.H. et al. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J. Exp. Med. 181, 1869-1874 (1995).
20. Tran, H.M. et al. J. Distinct mechanisms for the induction and maintenance of allograft tolerance with CTLA4-Fc treatment. J. Immunol. 159, 2232-2239 (1997).
21. Waldmann, H. & Cobbold, S. How do monoclonal antibodies induce tolerance? A role for infectious tolerance? Annu. Rev. Immunol. 16, 619-644 (1998).
22. Li, X.C., Zand, M.S., Li, Y., Zheng, X.X. & Strom, T.B. On histocompatibility barriers, Th1 to Th2 immune deviation, and the nature of the allograft responses. J. Immunol. 161, 2241-2247 (1998).
23. Tanchot, C. et al. Modifications of CD8+ T cell function during in vivo memory or tolerance induction. Immunity 8, 581-590 (1998).
24. Wells, A., Gudmundsdottir, H. & Turka, L. Following the fate of individual T cells throughout activation and clonal expansion: signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J. Clin. Invest. 100, 3173-3183 (1997).